LumineticsCore (formerly IDx-DR)
Digital Diagnostics
FDA cleareddiabetic retinopathydiabetic macular edemadiabetes screening
Autonomous software that reads retinal photographs and reports whether more-than-mild diabetic retinopathy is present, without a clinician interpreting the image. Originally the first FDA-authorized autonomous AI diagnostic.
- Company
- Digital Diagnostics
- Category
- Screening
- Reads
- Color fundus photographs (Topcon NW400 per vendor page)
- Built for
- Primary care, endocrinology, optometry and ophthalmology point-of-care settings screening adults with diabetes
- Billing
- CPT 92229 (per vendor page)
- Regulatory
- FDA De Novo DEN180001 (Apr 11, 2018, as IDx-DR); 510(k) K203629 (Jun 10, 2021); 510(k) K213037 IDx-DR v2.3 (Jun 17, 2022). Product code PIB. · source
- Last verified
- 2026-10-07
DotAEye is independent of Digital Diagnostics. Confirm indications, intended use, and clearance status with the manufacturer before clinical use.